Enovix (NASDAQ:ENVX) Sees Unusually-High Trading Volume

Enovix Co. (NASDAQ:ENVXGet Free Report) saw an uptick in trading volume on Friday . 4,364,532 shares traded hands during mid-day trading, a decline of 7% from the previous session’s volume of 4,679,499 shares.The stock last traded at $9.84 and had previously closed at $9.47.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. William Blair reaffirmed an “outperform” rating on shares of Enovix in a research note on Thursday. B. Riley reduced their price target on Enovix from $18.00 to $16.00 and set a “buy” rating on the stock in a research note on Tuesday. JPMorgan Chase & Co. lowered their price objective on Enovix from $18.00 to $12.00 and set an “overweight” rating for the company in a research report on Friday, April 26th. Craig Hallum decreased their price target on Enovix from $20.00 to $15.00 and set a “buy” rating on the stock in a research note on Thursday. Finally, Canaccord Genuity Group reiterated a “buy” rating and set a $17.00 price objective on shares of Enovix in a report on Wednesday, February 21st. One investment analyst has rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $25.29.

Read Our Latest Stock Analysis on Enovix

Enovix Stock Up 6.5 %

The stock has a market cap of $1.71 billion, a P/E ratio of -7.07 and a beta of 1.70. The firm has a 50 day simple moving average of $7.87 and a two-hundred day simple moving average of $10.01. The company has a debt-to-equity ratio of 0.65, a quick ratio of 5.15 and a current ratio of 5.30.

Enovix (NASDAQ:ENVXGet Free Report) last released its earnings results on Tuesday, February 20th. The company reported ($0.35) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.34) by ($0.01). Enovix had a negative return on equity of 83.66% and a negative net margin of 1,448.90%. The firm had revenue of $7.38 million during the quarter, compared to analyst estimates of $3.37 million. Equities research analysts predict that Enovix Co. will post -1.13 earnings per share for the current year.

Insider Buying and Selling

In other Enovix news, COO Ajay Marathe sold 4,954 shares of the company’s stock in a transaction dated Sunday, April 14th. The shares were sold at an average price of $7.31, for a total transaction of $36,213.74. Following the completion of the sale, the chief operating officer now directly owns 978,913 shares in the company, valued at $7,155,854.03. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 17.30% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Allspring Global Investments Holdings LLC bought a new stake in Enovix in the 3rd quarter valued at $31,000. Beacon Capital Management LLC raised its stake in Enovix by 66.7% during the 4th quarter. Beacon Capital Management LLC now owns 2,500 shares of the company’s stock worth $31,000 after buying an additional 1,000 shares during the period. Carmel Capital Partners LLC bought a new position in Enovix in the third quarter valued at approximately $34,000. Able Wealth Management LLC acquired a new position in shares of Enovix during the fourth quarter worth about $34,000. Finally, Quest Partners LLC bought a new position in shares of Enovix during the fourth quarter worth about $49,000. Institutional investors and hedge funds own 50.92% of the company’s stock.

About Enovix

(Get Free Report)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

See Also

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.